spacer
home > ict > Winter 2019
PUBLICATIONS

International Clinical Trials

ict
Winter 2019

   
Text
PDF
bullet
Clinical Trial Supply & Packaging
Adaptive Trial Designs

Redefining the Gold Standard

Detailing the process of a trial is pivotal to its success, and developing an adaptive trial can improve the outcome. However, there can be complications to this method, as demonstrated by Dr Chitra Lele and Dr Ritu Budania at Sciformix.
 
view
download pdf
Trial and No Error

The Evolution of Environmental Monitoring

Jukkapekka ‘JP’ Asikainen and Ossi Laakkonen at Sensire discuss the technicalities and subtleties of the technologies available to improve clinical trial supply and how best to select one. 



 
view
download pdf
bullet
Regional trials
Clinical Trials in Southeast Asia

Finding Future Markets

Namjoo Seo and Maree Ward at PRA Health Sciences examine Southeast Asia as a prime location for clinical trials while looking into the drawbacks of the region.
 
view
download pdf
bullet
THERAPEUTICS
Addressing an Epidemic

Improving Outcomes in Diabetes Research

Capturing and examining data is one of the most effective ways to understand the true number of diabetes sufferers and the associated complexities of the disease. Katie Garner at CRF Bracket explains more.
 
view
download pdf
bullet
Digital Advances
Developing Clinical Trial Designs with Artificial Intelligence

The Balanced Approach to Optimising Clinical Trial Design and Execution

Gen Li PhD, Paul Chew MD, and Jonathan Peachey at Phesi explore the different methods of artificial intelligence available to increase the chance of a successful trial, ultimately resulting in beneficial data.
 
view
download pdf
bullet
Vaccine Trials
Q&A: Pathological Rat Race

Animal Models to Study Infectious Pathogens

Carmen Sweeney PhD at Charles River spoke to ICT to provide insight into the use of cotton rats in animal models and why they could be an essential asset in fighting a wide variety of human pathogens.
 
view
download pdf
bullet
Features
CRA Recruitment

Specialist Shortage

Steve Lord at CK Clinical reviews future clinical research associates recruitment, how their roles are perceived in the industry, and how to encourage a career in clinical trials.
 
view
download pdf
Risk-Based Monitoring

Strategic Success

There are several complexities when dealing with risk-based monitoring. Patrick Hughes at CluePoints spoke to ICT to provide guidance on risk-based monitoring and how the right technology can drive it further.
 
view
download pdf
Automating Inventory Management in Healthcare

Automatic Improvements

Improving efficiency and accuracy is always a key target for healthcare facilities, and automation may provide the solutions for the industry. Jonathan Wilkins at EU Automation explores the available options.
 
view
download pdf
Helping Hearts

Concentration-QT Modelling in Early Phase Clinical Studies

With the development of new medications comes the risk of unexpected side effects. Dr Andreas Lindauer at SGS Exprimo explains how strict drug development assessment can avoid this issue.
 
view
download pdf
UK First-In-Human and Early Clinical Trials

Advancing Expansion

Dr Simon Hutchings at Simbec Research looks at the UK’s leading role in first-in-human clinical trials and how the experiences of each trial are enhancing the industry guidelines.
 
view
download pdf
 
 
download pdf
 
 
 
 
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August, and November

News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement